Author: Trent Ingle

Technimark Earns MedAccred Certification for El Paso Facility

Company currently pursuing new industry standard MedAccred certification for its other medical device facilities worldwide

ASHEBORO, N.C. (Jul, 6, 2021) – Technimark announced today that its production facility in El Paso, Texas, received its MedAccred certification from the Performance Review Institute. The facility, which is also ISO 13485:2016 certified and 21 CFR 820 compliant, specializes in medical contract manufacturing, including services such as custom injection molding, assembly and logistics operations for the medical device industry.

“Patient safety and quality are our highest priorities, and we are excited to partner with MedAccred to ensure our critical processes are best-in-class,” said Kris Peavy, president of Technimark’s Healthcare division. “The significant growth of our medical device business around the world, and specifically in our El Paso facility, made MedAccred certification a perfect fit. The accreditation helps us further demonstrate our expertise as a trustworthy and high-quality supplier in the medical device industry.  We’re currently pursuing accreditation at all of our medical facilities, and we expect them to be certified in the near future.”

The MedAccred certification program was developed by the Performance Review Institute, a non-for-profit organization that facilitates collaborative supply chain oversight programs, quality management systems approvals and professional development activities in industries that rely on high-quality, high-safety protocols. MedAccred is managed by the medical device OEMs, contract manufacturers and suppliers who collaborate to provide the sector with a trustworthy, evidence-based tool to ensure the suppliers’ processes and products meet the highest standards and improve product quality.

“Technimark is clearly committed to quality and improving patient safety by meeting the rigorous requirements set by technical experts in the medical device industry,” said Connie Conboy, director, MedAccred. “Technimark is a true leader in the medical device industry as demonstrated by their MedAccred Accreditation for Plastics Injection Molding at their El Paso, Texas facility.”

In describing the MedAccred certification process, the Performance Review Institute notes that preventing output deficiencies requires that critical processes and products be validated during manufacturing to prove that they are fit for purpose, satisfy regulatory requirements and reduce overall risk. The MedAccred certification does just this by:

  • Providing consistent, standardized critical process accreditation accepted by the Medical Device Industry resulting in fewer redundant onsite audits by multiple OEMs
  • Having Subject Matter Experts conduct in-depth critical process audits that are compliant and consistent with accepted industry/technical standards
  • Providing greater visibility of the supply chain to all levels and sub-tiers that provide critical processes, consistent with regulatory requirements (e.g., FDA, ISO 13485, MDD/MDR, etc.)
  • Improving the flow down of OEM requirements to sub-tier suppliers
  • Applying medical device industry-accepted and consistent technical requirements that yield process discipline, greater operational efficiency and continuous improvement resulting in higher quality and lower overall cost

Mr. Peavy explained that the audit is very thorough and drills into each individual process under review. “While MedAccred certification requires an ISO-certified quality management system, the process is not simply a QMS audit. Rather, it focuses on the key elements of the manufacturing process itself,” he said.

Audits are conducted by industry-approved and trained SME auditors on behalf of its subscribing OEM members using collaboratively created audit criteria. The accreditation is granted and accepted by the program’s subscribing OEM members. The audit criteria incorporate industry-accepted performance standards and manufacturer specifications that meet regulatory requirements.

“On behalf of Technimark and our clients, I want to thank the entire El Paso team for leading the way on this notable achievement,” Mr. Peavy said.


About Technimark

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging and specialty industrial market. Technimark specializes in precision injection molding, value-added assembly and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs and speed products to market. With facilities in the United States, Mexico, United Kingdom, Ireland, Germany and China, Technimark delivers high-quality products worldwide. For more information, visit technimark.com.

Posted in NewsTagged in , , ,

Oak Hill Capital Acquires Majority Stake in Technimark Holdings LLC

NEW YORK, June 7, 2021 – Oak Hill Capital (“Oak Hill”), a New York-based middle-market private equity firm, announced that it had agreed to acquire a controlling stake in Technimark Holdings LLC (“Technimark” or “the Company”) through Oak Hill’s fifth institutional fund, forming a partnership with current investors, Pritzker Private Capital (“PPC”) and management. The terms of the transaction were not disclosed.

Headquartered in Asheboro, North Carolina, Technimark is a leading designer and manufacturer of custom, highly-engineered injection molded components, which it sells to a group of global healthcare, consumer and specialty industrial customers. “We have a great deal of respect for what Technimark has accomplished, including its strong track-record of delivering industry leading quality and service to its customers,” said Brian Cherry, Managing Partner at Oak Hill. “We are delighted to partner with Technimark’s world class management team.”

“Technimark is a fantastic business with industry leading engineering and innovation capabilities and a very impressive list of global customers,” said John Rachwalski, a Partner at Oak Hill. “Thanks to strong leadership and smart, well-executed investments, Technimark is distinctively positioned to capitalize on the trends in its core target markets. We look forward to supporting the Company’s exciting growth agenda over the course of our partnership.”

The management team of Technimark, led by Chief Executive Officer Brad Wellington, will continue to lead the Company and retain a meaningful ownership stake. “Oak Hill is a firm that shares our collaborative culture and our growth vision for the business. We look forward to a successful partnership as we continue investing in Technimark’s manufacturing and innovation capabilities to drive best-in-class results for our customers,” said Wellington.

William Blair & Company served as financial advisor to Oak Hill on the transaction and Goldman Sachs & Co and Wells Fargo Securities, LLC acted as financial advisor to Technimark. Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as legal advisor to Oak Hill and Kirkland & Ellis LLP is serving as legal counsel to Technimark and PPC.

The transaction is expected to close in the third quarter of 2021 and represents the ninth investment in the Oak Hill Capital Partners V portfolio.

About Technimark Holdings LLC

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging and specialty industrial markets. Technimark specializes in precision injection molding, value-added assembly and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs and speed products to market. With facilities in the United Kingdom, United States, Mexico, China and Germany, Technimark delivers high-quality products worldwide. For more information, visit www.technimark.com.

About Oak Hill Capital

Oak Hill Capital is a private equity firm managing funds with over $16 billion of initial capital commitments and co-investments since inception. Over the past 35 years, Oak Hill Capital and its predecessors have invested in approximately 100 private equity transactions across broad segments of the U.S. and global economies. Oak Hill Capital applies an industry-focused, theme-based approach to investing in the following sectors: Industrials, Services, Media & Communications, and Consumer. Oak Hill works actively in partnership with management to implement strategic and operational initiatives to create franchise value. For more information, please visit: www.oakhill.com.

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit www.PPCPartners.com.

Media Contacts:
Dawn Dover / Emma Cloyd
Kekst CNC
917-349-5621 / 646-629-1191
dawn.dover@kekstcnc.com / emma.cloyd@kekstcnc.com

SOURCE Oak Hill Capital Partners

Posted in Employee info, NewsTagged in , ,

Technimark Will Manufacture and Package Innovative Nasal Swabs to Support Medical Community

Company partners with Rhinostics and P&G subsidiary iMFLUX to help increase access to advanced testing tools for COVID-19, influenza and other diseases

ASHEBORO, N.C. (April 26, 2021) – Technimark has partnered with Rhinostics and a P&G subsidiary, iMFLUX, to produce, package and distribute individually packaged medical-grade polypropylene nasal swabs to help healthcare professionals and researchers detect and diagnose potential infections such as COVID-19.

iMFLUX developed a novel fully injection-molded polypropylene nasal swab that P&G licensed to Rhinostics to bring to the clinical laboratory market. The novel swab allows for easy collection from the front of the nose and provides sample concentration of up to 30-fold over other swabs in viral transport media.

“Technimark is honored to join with other global leaders in healthcare innovation to address the increasing need for devices that can safely and accurately detect dangerous infections more quickly,” said Kris Peavy, president of Technimark’s Healthcare division. “Production of the medical-grade polypropylene nasal swabs will begin in April at Technimark’s headquarters in Asheboro. The swabs will be injection molded and packaged in an ISO Class 8 Cleanroom then sterilized prior to distribution.”

“We are proud to partner with Technimark, iMFLUX and P&G to bring new collection devices like the P&G nasal swab to clinical laboratory workflow,” said Cheri Walker, chief executive officer of Rhinostics. “Not only does the nasal swab production help to relieve supply chain bottlenecks, the new design and polypropylene materials allows for comfortable collection and sample concentration due to dry shipment and improved release of viral particles.”

Rhinostics plans to register the P&G polypropylene nasal swab as a Class I exempt medical device and will pursue Emergency Use Authorization for home collection with rPT-PCR testing, the gold standard for detection of SARS-CoV-2 infection.

“We are proud to see the P&G-developed nasal swab come to market through the efforts of Rhinostics and Technimark,” said Mary Wagner, senior vice president at P&G and CEO of iMFLUX. “When we began this program, our intention was simply to help relieve bottlenecks in COVID-19 swab supply and bring a novel collection device to bear on the problem.”

About Technimark

Technimark is a global manufacturing solutions provider for the healthcare, consumer packaging and specialty industrial market. Technimark specializes in precision injection molding, value-added assembly and full supply chain services. Technimark provides clients with customized, end-to-end solutions based on technology and innovation that improve quality, reduce risk, lower costs and speed products to market. With facilities in the United States, Mexico, United Kingdom, Ireland, Germany and China, Technimark delivers high-quality products worldwide. For more information, visit technimark.com.

About Rhinostics

Rhinostics Inc. commercializes simple and elegant solutions to bring efficiencies and cost savings to the laboratory workflow. The Rhinostics nasal swab provides features that increase sample throughput by more than 10-fold while removing labor and errors from the laboratory workflow. The swab is integrated onto a cap that can be automated for removal from the tube while all 96 samples are simultaneously accessioned through scanning a 2D barcode on the bottom of the tubes. The product provides an immediate impact to increasing COVID testing efficiencies while being applicable to broader respiratory viral, bacterial, and genetic testing using the polymerase chain reaction (PCR) and next generation sequencing (NGS). The Rhinostics product is registered as Class I exempt medical device with the FDA and is available for purchase. To learn more, visit https://www.rhinostics.com.

About iMFLUX

A subsidiary of P&G, iMFLUX is a team of innovators, operating globally to transform the future of plastic injection molding. Join us on our journey to autonomous molding™ and learn how we provide meaningful sustainability solutions. Please visit www.imflux.com for more information about iMFLUX, our patented game-changing processing software, and our mold design and innovation center.

Posted in NewsTagged in ,

Technimark Expands Role of Key Executive

Technimark is pleased to announce that Kris Peavy, Technimark’s Chief Commercial Officer, has also been named President of Technimark Healthcare. This will expand Kris’ current accountabilities to include P&L oversight for our global Healthcare business. In this role, Kris will be able to provide more support to Technimark’s rapidly growing Healthcare segment to ensure strategic growth and profitability. 

Kris has been with Technimark since 2010 and has been instrumental in helping build Technimark’s Healthcare business. The expansion of his responsibility will enable him to support the division for the future.   

Posted in Employee infoTagged in ,

Technimark Acquires European Injection Molder, Tool & Plastic Industries Ltd., Expanding Global Manufacturing Platform And Healthcare Focus

Global plastic injection molding leader adds facilities in Ireland and the Czech Republic

ASHEBORO, N.C., (July 14, 2020) – Technimark, a global manufacturer of custom rigid plastic packaging and components, announced today it has acquired Tool & Plastic Industries Ltd., a leading supplier of injection molded products for the medical device, pharmaceutical and consumer product sectors. The company is headquartered in Longford, Ireland, with an additional facility in Ostrava, Czech Republic. Financial terms of the transaction were not disclosed. Technimark is backed by Pritzker Private Capital.

Tool & Plastic, in operation for 52 years and led by owners Colm Cuffe and Declan O’Rourke, specializes in offering competitive and innovative contract GMP Cleanroom molding and assembly solutions. The company operates from a number of ISO Class 8 Cleanroom environments in its facility in Ireland and from an IATF 16949 compliant facility in the Czech Republic. Tool & Plastic has continually invested in state-of-the-art technology, allowing for high-quality manufacturing services and a longstanding reputation for excellence.

The combination of Tool & Plastic and Technimark enhances Technimark’s healthcare manufacturing expertise, as well as its global footprint. The combined company will have 13 facilities and over 4,400 employees worldwide.

“We are excited to partner with Technimark,” commented Mr. Cuffe. “Tool & Plastic and Technimark share a common culture for technical excellence, safety, innovation and customer partnership, and we look forward to building lasting value together.”

Mr. O’Rourke added “The acquisition by Technimark represents a strategic fit for the business in Ireland and the Czech Republic, and we look forward to developing and growing the business on the solid foundation already in place.”

“Tool & Plastic’s leadership in its core healthcare markets, combined with Technimark’s manufacturing expertise, healthcare customer relationships, and scale create a market leader with significant opportunities for future growth,” said Brad Wellington, CEO of Technimark. “Tool & Plastic will help us deliver even more value to our customers, and we are excited to welcome them to the Technimark family.”

Thomas Chadwick, vice president at Pritzker Private Capital, added, “This acquisition represents an important growth opportunity for Technimark and adds two state-of-the-art facilities in key geographies that will help accelerate growth of the combined business. We look forward to a successful partnership ahead.”

“By enhancing our ability to serve customers across Western and Eastern Europe, these acquisitions bolster our long-term growth strategy in the global healthcare market,” Mr. Wellington said. “Technimark is well-positioned to help our clients apply advanced and innovative technology-based solutions from design and engineering through production, including assembly and packaging of the final product.”

About Technimark

Technimark is a leading, global provider of custom rigid plastic packaging and components. Family-founded and led for more than 30 years, Technimark has provided customers with customized, end-to-end solutions based on technology and innovation. With facilities in the United Kingdom, United States, Mexico, China and Germany, Technimark delivers high quality products on a global basis for healthcare, consumer packaged goods and specialty industrial customers. For more information, visit technimark.com.

About Tool & Plastic Industries, Ltd.

Founded in 1968 and headquartered in Longford, Ireland, Tool & Plastic Industries is a leading supplier of precision injection molded plastic components to the global medical device, pharmaceutical and consumer product sectors. Operating out of facilities in Ireland and the Czech Republic, the Company serves an international blue-chip customer base, including leading OEM’s in its sectors of service. Tool & Plastic is ISO 13485-certified and operates from a number of ISO Class 8 Cleanroom environments. For more information, visit toolandplastic.com.

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur and family owned companies. For more information, visit ppcpartners.com.

###

Posted in NewsTagged in , , ,

Technimark’s innovation team 3D-prints and assembles face shields for employees and hospital workers

Product Design Engineer assembles 3D printed face shields in ADM lab

Technimark’s innovation team, based in Asheboro, NC, is using technology and creativity to find ways to protect their fellow employees as well as healthcare workers on the front line of this crisis. Using a public domain design, they have been 3D-printing components and hand constructing face shields as quickly as they can.

So far, they’ve produced hundreds of shields, and they are working on ways to ramp up production further. The shields are being distributed to regional hospitals, health care professionals, and employees (where required).

Winning the battle against something as powerful as COVID-19 takes commitment, concentration, and creativity. The Technimark team of innovation specialists is doing all that and more to find ways to protect their fellow employees and those on the front lines of this healthcare crisis.

Posted in NewsTagged in , , ,

Technimark Executives Personally Contribute Money to Ensure Employees Have 100% Health Coverage for COVID-19-Related Costs

Our employees are superstars, and in recognition of their value and the potential financial burdens of COVID-19, we’re pleased to announce that beginning today, Technimark will cover 100% of all testing and treatment of COVID-19 for our U.S. employees and eligible dependents who are currently enrolled in our health insurance plan. This includes all coinsurance and copay costs for medical treatments.

As a self-insured company, Technimark is not required to provide full COVID-19 coverage for employees. However, in keeping with our values, we are providing the coverage to minimize the financial impact on our employees in the unfortunate event they contract the virus.

These are extraordinary times and we’re confident that together, we will defeat this dreadful virus and emerge stronger as individuals, as a community, and as a company. Until then, stay safe, stay sanitized, and stay 6 feet away!

Posted in Employee infoTagged in , , , ,

Technimark’s COVID-19 Response

March 24th, 2020

Together, we are facing a truly unprecedented situation. The global COVID-19 pandemic is affecting all our families, our businesses, our communities, and our way of life. During this challenging time, it is our commitment to deliver you continuous updates on how this situation is impacting Technimark, our overall response strategy and how our customers may be impacted. 

We remain focused on ensuring the health of our employees, deterring the spread of the virus and the seamless flow of high-quality products for our customers.  Given the critical nature of this situation, we wanted to share a few key updates we felt would be valuable.  

Technimark is classified as a “ESSENTIAL BUSINESS” business in the U.S.

Many of the products Technimark manufactures are considered lifesaving, critical for care, or necessary for people to keep themselves and their environments clean and healthy.  For these reasons and per the Department of Homeland Security’s Critical Infrastructure guidelines, Technimark is classified as an Essential Business during the COVID-19 pandemic crisis by the Federal Government and every State in which we operate. Which means our facilities are approved to remain in business and expected to continue production during this unprecedented event.  By definition, critical infrastructure industries are those ‘whose assets, systems, and networks, whether physical or virtual, are considered so vital to the United States that their incapacitation or destruction would have a debilitating effect on security, national economic security, national public health or safety, or any combination thereof’ (from the DHS fact sheet on Critical Infrastructure Sectors).  

Technimark is operating per best practices guidance given by the CDC, Government Leadership and Health Departments  

Technimark is taking preemptive and best practice actions in all our facilities around the world to ensure the safety of our employees and to deter the spread of the virus.  Our team, along with support from external experts, continues to develop and implement companywide coronavirus strategies and action plans as the situation evolves. 

More specifically, Technimark has formed a COVID-19 Leadership Team who has pandemic oversite, assuring proper knowledge and resources are available at each site.  Below are some of the elements of our global response plan, including:

  • Sharing frequent updates with our employees in multiple formats – open communication is paramount to this effort
  • Implemented training and resources for proper cleaning and disinfecting along with a regimented schedule
  • Implemented social distancing techniques and guidelines in our manufacturing facilities
  • Providing masks to employees and requiring them to be worn while at work
  • Asking all employees that can work remotely to do so
  • Set strict travel restrictions
  • Established protocols for an actual or suspected outbreak
  • Enforcing return-to-work guidelines for different potential quarantine situations
  • Temperature checking for staff and visitors prior to allowing site accesses
  • Greatly limiting visitors/contractor access and implementing a pre-visit assessment of each necessary non-employee entrant to our facilities
  • Clearly instructing employees who are symptomatic for COVID-19 to not come to work

Rest assured, Technimark’s focus remains on providing an uninterrupted supply of quality products, and we will actively monitor this situation and communicate any and all updates. We will continue to evaluate and identify risks in our supply chain, and we will implement mitigation plans where required.   Working together with increased communication and transparency, we will get ahead of any challenges and quickly address issues as they come up.  If you have any questions, please do not hesitate to contact your Technimark account and customer service team.

Finally, and most importantly, our hearts go out to everyone who has been impacted by the virus, either directly or indirectly. We extend our heartfelt wishes. 

Posted in NewsTagged in , ,

Rapid Growth Prompts Expansion for Technimark Healthcare

Major additions in Pennsylvania and Texas will meet increasing demand

Latrobe, Pa. (Sept. 6, 2018) — Prompted by rapid growth of its healthcare business, Technimark broke ground on an 80,000-square-foot addition to its Latrobe, Pa. healthcare manufacturing facility, nearly doubling the size of its existing plant there. The company announced a similar expansion at its El Paso, TX facility.

Technimark is a global manufacturer of custom rigid plastic solutions for the consumer packaging, healthcare and industrial markets, and is owned by PPC Partners along with management.

At a recent groundbreaking ceremony at the Pennsylvania plant, Technimark officials said the expansions are needed to meet increasing demand for the services of its healthcare division.

“A key element in our business strategy is a commitment to ensure we have state-of-the-art facilities and services that allow us to serve our customers’ current and future manufacturing needs,” said Brad Wellington president and CEO. “Our expansions in Latrobe and El Paso are examples of that commitment. Over the past few years, we have built or expanded a number of ISO-certified cleanrooms in Pennsylvania, Texas, Mexico, the United Kingdom, and China.”

Technimark acquired Latrobe-based Ci Medical Technologies, a top manufacturer of injection-molded components used in medical, pharmaceutical and consumer healthcare products, in 2015. The company’s healthcare division currently produces a variety of specialty medical components and finished medical devices for various key healthcare markets, including surgical, diagnostics, life science, pharmaceutical and consumer healthcare, among others.

According to John Rugari, vice president of sales for Technimark Healthcare, the company currently serves customers worldwide from 14 manufacturing facilities across North America, Europe and Asia. “Our value proposition is resonating strongly in the healthcare market and, as a result, our pipeline of new contracts from our strategic customers and new customers is exceptionally strong. That robust pipeline is driving our growth and need for expansions around the world,” Mr. Rugari said. He noted Technimark Healthcare facilities meet all applicable ANSI and ISO 9001 and ISO 13485 standards, as well as all relevant FDA regulations for the manufacture of medical products.

Scott Irvine, the Latrobe facility’s director of human resources, noted that Technimark Healthcare currently has a number of open positions in Latrobe for engineers, tool makers and operations staff and will begin recruitment for the new jobs soon. In addition to highly competitive pay and benefits, he noted the company offers employees a range of pathways to advance their careers, including Technimark University, a comprehensive in-house training facility.

Posted in NewsTagged in , ,